ENTITY
Amgen

Amgen (AMGN UW)

5
Analysis
Health Care • United States
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures, and markets medicines for grievous illnesses. The Company focuses on human therapeutics and concentrates on innovating novel medicines based on cellular and molecular biology.
more
•06 Aug 2024 10:43•Broker

US Trade Balance and EU Retail Sales

Technically, the SET Index is expected to fall, with the support at 1,265/1,250 points and the resistance at 1,281/1,286 points. In the short...

Logo
93 Views
Share
•02 May 2024 10:33•Broker

EU's Manufacturing PMI in April and Earnings Results

Technically, we expect the SET Index to move sideways up, with the resistance at 1,376/1,384 points (50-day EMA and 75-day EMA) and the support at...

Logo
96 Views
Share
bullish•B.Grimm Power
•31 Jan 2023 10:41•Broker

Recommendation: Buy on Weakness, Sell on Strength

The SET Index is expected to move sideways, with the support at 1,670/1,665 points and the resistance at 1,690/1,700 points. Tactically, investors...

Logo
95 Views
Share
x